Latest News
May 10, 2021
Not intended for U.S. and UK Media - American College of Cardiology’s 70th Annual Scientific Session (ACC.21):
Bayer announces two late-breaking presentations which include data from FIDELIO-DKD (finerenone) and VOYAGER PAD (Xarelto™) Phase III studies
May 10, 2021
Not intended for U.S. and UK Media
Bayer’s finerenone meets primary endpoint in Phase III FIGARO-DKD cardiovascular outcomes study in patients with chronic kidney disease and type 2 diabetes
April 27, 2021
Explanations to the Supervisory Board Report - Prof. Dr. Norbert Winkeljohann
April 27, 2021
Address by Werner Baumann
April 10, 2021
Not intended for U.S. and UK Media – Plenary Session at AACR Annual Meeting 2021:
Combination of copanlisib and rituximab significantly increases progression-free survival in patients with relapsed indolent non-Hodgkin's Lymphoma
Global Health Policy Blog
Current Topics
All